type here...

CATEGORIES

Medication

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life -
Today the Pharmacy Podcast Network announces the winners of the 50 Most Influential Leaders in Pharmacy 2023 Awards. 

Does Botox Drop Anxiety?

Michael Hunter, MD -
WITH DISEASE SPREAD AND DEATHS, large outbreaks of Covid-19 infection are associated with fear and grief. I don't know about you, but the limits on...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories